Back to Peptides
RecoveryMedium Risk

TB-500

Also known as: Thymosin Beta-4, Tβ4

Half-life:
5–7 days

Administration Routes

subcutaneous
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

TB-500 exerts its effects primarily through promotion of actin polymerisation and cell migration. It upregulates the expression of beta-4 thymosin, which facilitates endothelial and muscle satellite cell movement to injury sites. Unlike BPC-157, TB-500 appears to act via a more systemic mechanism rather than locally at the administration site.

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide found in nearly all human cells. It is researched for its role in promoting cellular repair, angiogenesis, and immune modulation, particularly in the context of musculoskeletal recovery and tissue healing after acute injury.

Primary Research Areas

  • recovery
  • performance

Risk Profile

Medium Risk

Moderate risk profile in research contexts. Consult a healthcare professional before use.

Providers Offering TB-500